What is APNEV's earnings per share (EPS)?

APNEV (APNEV) reported diluted earnings per share of -$0.22 for fiscal year 2025. This represents a -257.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

APNEV Financials

APNEV

Trailing 12 months to March 31, 2026

Revenue $64.7M +19.9% YoY

Net Income $707K -38.4% YoY

EPS (Diluted) -$0.22 FY2025 annual

Free Cash Flow -$216.3M -29.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Apr 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Apr 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the APNEV SEC filings page.

APNEV (APNEV) reported $64.7M in revenue over the twelve months to Mar 31, 2026, up 19.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI APNEV FY2025 2026-08-30

Capital-intensive, debt-funded model converts operating earnings into persistent cash deficits despite revenue expansion.

From FY2022 to FY2025, revenue rose to $60.5M while operating margin compression brought the margin to 21.7%, showing added scale did not translate proportionally into operating profit. The more revealing cash-conversion gap is that FY2025 operating cash flow was $25.8M against free cash flow of -$218.7M, meaning reinvestment—not day-to-day operations—drove the cash shortfall.

Debt-to-equity rose from 1.0x in FY2022 to 1.3x in FY2025 as the asset base expanded, indicating a more leveraged funding structure rather than self-funded expansion.

Capital intensity is pronounced: FY2025 capital expenditures reached $244.5M while operating cash flow was $25.8M, so investment consumed far more cash than operations produced. Interest expense reached $16.3M, helping explain how positive operating income coexisted with a net loss.

Financial Health Signals

Financial health score not available

APNEV does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/8

APNEV passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

APNEV reported a net loss of $2.7M while generating $25.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.81x

APNEV earns $0.81 in operating income for every $1 of interest expense ($13.1M vs $16.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$18.4M

YoY+29.6%

QoQ+8.9%

5Y CAGR+25.6%

APNEV generated $18.4M in revenue in Q1 2026. This represents an increase of 29.6% from the same quarter a year earlier. Against the prior quarter it is up 8.9%.

EBITDA

$13.8M

YoY+44.5%

QoQ+8.6%

5Y CAGR+26.9%

APNEV's EBITDA was $13.8M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 44.5% from the same quarter a year earlier. Against the prior quarter it is up 8.6%.

Net Income

$2.2M

YoY+285.3%

QoQ+48.3%

5Y CAGR+37.8%

APNEV reported $2.2M in net income in Q1 2026. This represents an increase of 285.3% from the same quarter a year earlier. Against the prior quarter it is up 48.3%.

EPS (Diluted)

$0.06

APNEV earned $0.06 per diluted share (EPS) in Q1 2026.

Cash & Balance Sheet

Free Cash Flow

-$53.2M

YoY+4.3%

QoQ+52.3%

APNEV recorded an outflow of $53.2M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents an increase of 4.3% from the same quarter a year earlier. Against the prior quarter it is up 52.3%.

Cash & Debt

$2.6M

YoY-57.3%

QoQ-43.0%

5Y CAGR+11.1%

APNEV held $2.6M in cash against $359.4M in long-term debt as of Q1 2026.

Dividends Per Share

$0.30

APNEV paid $0.30 per share in dividends in Q1 2026.

Shares Outstanding

17M

QoQ+9.5%

5Y CAGR+15.8%

APNEV had 17M shares outstanding in Q1 2026. Against the prior quarter it is up 9.5%.

Margins & Returns

Operating Margin

36.0%

YoY+20.0pp

QoQ+0.7pp

5Y change+17.9pp

APNEV's operating margin was 36.0% in Q1 2026, reflecting core business profitability. This is up 20.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Net Margin

11.9%

YoY+20.2pp

QoQ+3.1pp

5Y change+4.4pp

APNEV's net profit margin was 11.9% in Q1 2026, showing the share of revenue converted to profit. This is up 20.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.1 percentage points.

Return on Equity

0.7%

YoY+1.2pp

QoQ+0.2pp

5Y change+0.4pp

APNEV's ROE was 0.7% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Gross Margin

Not reported for Q1 2026.

Capital Allocation

Capital Expenditures

$57.5M

YoY-6.3%

QoQ-49.3%

APNEV invested $57.5M in capex in Q1 2026, funding long-term assets and infrastructure. This represents a decrease of 6.3% from the same quarter a year earlier. Against the prior quarter it is down 49.3%.

R&D Spending

Not reported for Q1 2026.

Share Buybacks

Not reported for Q1 2026.

APNEV Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

APNEV quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18
Revenue	$64.7M	$60.5M+15.9%	$52.2M+14.4%	$45.6M+1.0%	$45.2M+50.0%	$30.1M+56.5%	$19.2M+62.6%	$11.8M+1.0%	$11.7M
Gross Profit	N/A	$52.1M+18.4%	$44.0M+12.7%	$39.0M-1.8%	$39.8M	N/A	N/A	N/A	N/A
SG&A Expenses	$6.9M	$6.7M+2.0%	$6.6M+4.3%	$6.3M+8.9%	$5.8M+15.1%	$5.0M+7.9%	$4.7M+176.9%	$1.7M+42.1%	$1.2M
Operating Income	$17.5M	$13.1M-6.3%	$14.0M+6.6%	$13.1M-69.8%	$43.5M+186.8%	$15.2M+480.9%	$2.6M-28.1%	$3.6M-9.6%	$4.0M
EBITDA	N/A	$40.5M+2.3%	$39.6M+1.8%	$38.9M-42.0%	$67.0M+115.6%	$31.1M+147.6%	$12.6M+47.9%	$8.5M-4.8%	$8.9M
Interest Expense	$17.0M	$16.3M+35.5%	$12.0M+18.1%	$10.2M+6.6%	$9.5M+157.7%	$3.7M+152.9%	$1.5M	N/A	N/A
Net Income	$707K	-$2.7M-228.6%	$2.1M-29.2%	$2.9M-90.2%	$29.7M+198.3%	$10.0M+911.6%	$985K-72.9%	$3.6M-9.6%	$4.0M
EPS (Basic)	N/A	-$0.22-246.7%	$0.15-28.6%	$0.21-91.5%	$2.48+143.1%	$1.02+684.6%	$0.13	N/A	N/A
EPS (Diluted)	—	-$0.22-257.1%	$0.14-26.3%	$0.19-91.2%	$2.17+143.8%	$0.89+709.1%	$0.11	N/A	N/A
Diluted Shares (Avg)	N/A	16M+3.1%	15M-3.1%	16M+13.8%	14M+21.6%	11M+27.6%	9M	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$18.4M+29.6%	$16.9M+22.5%	$14.6M+8.0%	$14.9M+19.0%	$14.2M+14.0%	$13.8M+19.1%	$13.5M+16.6%	$12.5M+10.1%
SG&A Expenses	$1.9M+8.3%	$1.6M+0.8%	$1.7M-8.0%	$1.7M+5.9%	$1.7M+11.3%	$1.6M+7.4%	$1.8M+11.6%	$1.6M-3.3%
Operating Income	$6.6M+191.7%	$6.0M+201.7%	$2.4M-62.6%	$2.5M-16.9%	$2.3M-12.2%	$2.0M-33.7%	$6.5M+368.5%	$3.0M+23.0%
EBITDA	$13.8M+44.5%	$12.7M+49.9%	$9.0M-29.6%	$9.2M-1.6%	$9.6M+6.8%	$8.5M-10.1%	$12.8M+61.9%	$9.3M+5.5%
Interest Expense	$4.4M+21.2%	$4.4M+44.5%	$3.9M+23.5%	$4.3M+52.6%	$3.6M+22.4%	$3.1M+15.1%	$3.2M+29.6%	$2.8M+16.1%
Net Income	$2.2M+285.3%	$1.5M+253.8%	-$1.3M-142.5%	-$1.6M-904.4%	-$1.2M-353.5%	-$958K-386.0%	$3.1M+468.0%	$204K+155.0%
EPS (Basic)	$0.07+187.5%	N/A	-$0.09-140.9%	-$0.12-1300.0%	-$0.08-300.0%	N/A	$0.22+466.7%	$0.010.0%
EPS (Diluted)	$0.06	N/A	-$0.09-142.9%	-$0.12-1300.0%	-$0.08-300.0%	N/A	$0.21+520.0%	$0.01
Diluted Shares (Avg)	17M	N/A	15M+2.8%	15M+3.9%	16M+6.8%	N/A	15M-4.4%	15M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Income Tax.

APNEV Balance Sheet

APNEV quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18
Total Assets	$715.9M+18.3%	$605.0M+7.2%	$564.6M-1.5%	$573.4M+13.4%	$505.5M+92.8%	$262.2M+59.7%	$164.2M	N/A
Cash & Equivalents	$4.6M+190.8%	$1.6M-60.7%	$4.0M-55.4%	$9.0M+1.9%	$8.9M+367.3%	$1.9M-84.7%	$12.3M+154175.0%	$8K
Total Liabilities	$414.6M+26.2%	$328.5M+13.7%	$288.9M+3.9%	$278.1M+0.2%	$277.6M+145.4%	$113.1M+3162.6%	$3.5M	N/A
Long-Term Debt	$377.7M+25.3%	$301.5M+9.4%	$275.7M+3.2%	$267.1M-0.2%	$267.7M+150.7%	$106.8M	N/A	N/A
Total Equity	$279.9M+10.6%	$253.0M+0.9%	$250.7M-4.2%	$261.6M+33.1%	$196.5M+55.0%	$126.8M-7.8%	$137.5M+10.7%	$124.2M
Retained Earnings	-$35.3M-124.4%	-$15.7M-566.5%	-$2.4M-123.5%	$10.0M+256.4%	-$6.4M-12.4%	-$5.7M-1047.2%	-$498K	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$745.1M+15.1%	$715.9M+18.3%	$621.4M+7.3%	$628.4M+11.1%	$647.4M+15.8%	$605.0M+7.2%	$579.0M+3.8%	$565.8M-0.2%
Cash & Equivalents	$2.6M-57.3%	$4.6M+190.8%	$1.2M-53.8%	$5.0M+53.4%	$6.1M+19.3%	$1.6M-60.7%	$2.6M-59.1%	$3.3M-58.0%
Total Liabilities	$411.5M+7.3%	$414.6M+26.2%	$376.2M+22.5%	$376.4M+26.5%	$383.6M+34.1%	$328.5M+13.7%	$307.0M+17.3%	$297.4M+13.3%
Long-Term Debt	$359.4M+0.8%	$377.7M+25.3%	$358.2M+28.4%	$352.6M+31.4%	$356.5M+30.9%	$301.5M+9.4%	$278.9M+12.0%	$268.3M+7.8%
Total Equity	$312.5M+29.7%	$279.9M+10.6%	$223.5M-10.0%	$229.8M-5.8%	$240.9M-2.9%	$253.0M+0.9%	$248.2M-5.7%	$244.0M-10.0%
Retained Earnings	-$39.1M-85.9%	-$35.3M-124.4%	-$32.1M-201.0%	-$26.7M-169.7%	-$21.0M-230.7%	-$15.7M-566.5%	-$10.7M-1090.9%	-$9.9M-272.9%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

APNEV Cash Flow Statement

APNEV quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18
Operating Cash Flow	$24.3M	$25.8M+9.9%	$23.4M+1.1%	$23.2M-6.0%	$24.7M+43.3%	$17.2M+83.1%	$9.4M+24.5%	$7.5M+34.2%	$5.6M
Depreciation & Amortization	N/A	$27.4M+7.0%	$25.6M-0.6%	$25.8M+9.3%	$23.6M+47.8%	$15.9M+60.2%	$9.9M+104.8%	$4.9M-0.9%	$4.9M
Stock-Based Compensation	N/A	$380K+53.8%	$247K-22.3%	$318K+2.6%	$310K+0.3%	$309K+15.3%	$268K-47.3%	$509K+119.4%	$232K
Capital Expenditures	$240.6M	$244.5M+84.7%	$132.4M+10.4%	$119.9M-36.6%	$189.1M-15.3%	$223.4M	N/A	N/A	N/A
Free Cash Flow	-$216.3M	-$218.7M-100.7%	-$109.0M-12.6%	-$96.7M+41.2%	-$164.5M+20.2%	-$206.2M	N/A	N/A	N/A
Investing Cash Flow	-$81.1M	-$103.9M-86.6%	-$55.7M-401.3%	-$11.1M+71.4%	-$38.8M+80.2%	-$196.0M-72.1%	-$113.9M-321.7%	-$27.0M-420.7%	-$5.2M
Financing Cash Flow	$72.3M	$109.2M+312.6%	$26.5M+332.6%	-$11.4M-164.4%	$17.7M-90.5%	$186.4M+98.2%	$94.0M+383.5%	$19.4M+4540.0%	-$438K
Dividends Paid	$18.5M	$17.7M+5.7%	$16.8M-1.6%	$17.1M+12.9%	$15.1M+24.3%	$12.2M+68.9%	$7.2M	N/A	N/A
Share Buybacks	N/A	$8.8M+1035.2%	$775K-94.7%	$14.6M	N/A	N/A	$5.0M	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$4.4M-25.2%	$2.1M-13.3%	$8.7M+40.5%	$9.1M+13.3%	$5.8M-13.8%	$2.4M-45.3%	$6.2M+22.6%	$8.0M-3.2%
Depreciation & Amortization	$7.2M-1.3%	$6.8M+3.9%	$6.6M+4.1%	$6.7M+5.6%	$7.3M+14.5%	$6.5M+0.7%	$6.3M-2.9%	$6.4M-1.1%
Stock-Based Compensation	$95K0.0%	N/A	N/A	N/A	$95K+20.3%	N/A	N/A	N/A
Capital Expenditures	$57.5M-6.3%	$113.5M+99.7%	$57.5M+16.7%	$12.1M-43.9%	$61.4M+1196.1%	$56.9M+79.8%	$49.3M+85.2%	$21.5M-65.0%
Free Cash Flow	-$53.2M+4.3%	-$111.4M-104.7%	-$48.8M-13.3%	-$3.0M+78.0%	-$55.5M-2842.9%	-$54.4M-100.2%	-$43.0M-100.0%	-$13.5M+74.7%
Investing Cash Flow	-$25.3M+47.4%	-$44.6M+7.3%	-$15.3M-703.7%	$4.2M+378.4%	-$48.1M-1071.6%	-$48.1M-131.9%	-$1.9M+70.4%	-$1.5M+96.2%
Financing Cash Flow	$9.0M-80.4%	$74.9M+192.4%	$1.1M-93.6%	-$12.7M-57.2%	$45.9M+645.7%	$25.6M+102.7%	$17.4M+291.9%	-$8.1M-70.4%
Dividends Paid	$5.3M+17.4%	$4.5M+0.5%	$4.4M+5.3%	$4.4M+7.3%	$4.5M+10.1%	$4.5M+8.5%	$4.2M-2.8%	$4.1M-5.7%
Share Buybacks	N/A	$0	$0	$4.3M	$4.5M+478.3%	$0-100.0%	$0-100.0%	$0

APNEV Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

APNEV quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18
Gross Margin	86.0%+1.8pp	84.2%-1.3pp	85.5%-2.5pp	88.0%	N/A	N/A	N/A	N/A
Operating Margin	21.7%-5.1pp	26.8%-2.0pp	28.8%-67.4pp	96.2%+45.9pp	50.3%+36.8pp	13.6%-17.1pp	30.7%-3.6pp	34.3%
Net Margin	-4.4%-8.3pp	4.0%-2.4pp	6.4%-59.4pp	65.8%+32.7pp	33.1%+27.9pp	5.1%-25.6pp	30.7%-3.6pp	34.3%
Return on Equity	-0.9%-1.8pp	0.8%-0.3pp	1.2%-10.2pp	11.4%+6.3pp	5.1%+4.3pp	0.8%-1.9pp	2.6%-0.6pp	3.2%
Return on Assets	-0.4%-0.7pp	0.3%-0.2pp	0.5%-4.7pp	5.2%+3.2pp	2.0%+1.6pp	0.4%-1.8pp	2.2%	N/A
Debt-to-Equity	1.35+0.2x	1.19+0.1x	1.10+0.1x	1.02-0.3x	1.36+0.5x	0.84+0.8x	0.03	N/A
Asset Turnover	0.080.0x	0.090.0x	0.080.0x	0.080.0x	0.060.0x	0.070.0x	0.07	N/A
FCF Margin	-361.3%	-208.6%	-211.9%	-364.0%	-684.5%	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Margin	36.0%+20.0pp	35.3%+20.9pp	16.6%-31.3pp	16.8%-7.2pp	16.0%-4.7pp	14.3%-11.4pp	47.9%+36.0pp	24.0%+2.5pp
Net Margin	11.9%+20.2pp	8.7%+15.7pp	-9.0%-31.9pp	-11.0%-12.7pp	-8.3%-6.2pp	-7.0%-9.8pp	22.9%+30.1pp	1.6%+0.9pp
Return on Equity	0.7%+1.2pp	0.5%+0.9pp	-0.6%-1.8pp	-0.7%-0.8pp	-0.5%-0.4pp	-0.4%-0.5pp	1.2%+1.6pp	0.1%+0.1pp
Return on Assets	0.3%+0.5pp	0.2%+0.4pp	-0.2%-0.7pp	-0.3%-0.3pp	-0.2%-0.1pp	-0.2%-0.2pp	0.5%+0.7pp	0.0%0.0pp
Debt-to-Equity	1.15-0.3x	1.35+0.2x	1.60+0.5x	1.53+0.4x	1.48+0.4x	1.19+0.1x	1.12+0.2x	1.10+0.2x
Asset Turnover	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.020.0x
FCF Margin	-288.9%	-659.4%	-334.9%	-20.0%	-391.0%	-394.8%	-319.3%	-108.0%

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.

Where APNEV Ranks

Frequently Asked Questions

What is APNEV's annual revenue?

APNEV (APNEV) reported $60.5M in total revenue for fiscal year 2025. This represents a 15.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is APNEV's revenue growing?

APNEV (APNEV) revenue grew by 15.9% year-over-year, from $52.2M to $60.5M in fiscal year 2025.

Is APNEV profitable?

No, APNEV (APNEV) reported a net income of -$2.7M in fiscal year 2025, with a net profit margin of -4.4%.

What is APNEV's EBITDA?

APNEV (APNEV) had EBITDA of $40.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does APNEV have?

As of fiscal year 2025, APNEV (APNEV) had $4.6M in cash and equivalents against $377.7M in long-term debt.

What is APNEV's gross margin?

APNEV (APNEV) had a gross margin of 86.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is APNEV's operating margin?

APNEV (APNEV) had an operating margin of 21.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is APNEV's net profit margin?

APNEV (APNEV) had a net profit margin of -4.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does APNEV pay dividends?

Yes, APNEV (APNEV) paid $1.14 per share in dividends during fiscal year 2025.

What is APNEV's return on equity (ROE)?

APNEV (APNEV) has a return on equity of -0.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is APNEV's free cash flow?

APNEV (APNEV) recorded an outflow of $218.7M in free cash flow during fiscal year 2025. This represents a -100.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is APNEV's operating cash flow?

APNEV (APNEV) generated $25.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are APNEV's total assets?

APNEV (APNEV) had $715.9M in total assets as of fiscal year 2025, including both current and long-term assets.

What are APNEV's capital expenditures?

APNEV (APNEV) invested $244.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does APNEV buy back shares?

Yes, APNEV (APNEV) spent $8.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does APNEV have outstanding?

APNEV (APNEV) had 15M shares outstanding as of fiscal year 2025.

What is APNEV's debt-to-equity ratio?

APNEV (APNEV) had a debt-to-equity ratio of 1.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is APNEV's return on assets (ROA)?

APNEV (APNEV) had a return on assets of -0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is APNEV's Piotroski F-Score?

APNEV (APNEV) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are APNEV's earnings high quality?

APNEV (APNEV) reported a net loss of $2.7M while generating $25.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can APNEV cover its interest payments?

APNEV (APNEV) has an interest coverage ratio of 0.81x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.